Among variant-positive males (N = 81), 2 (2.5%) had breast cancer (BRCA1 c.5266dupC and BRCA2 c.4471_4474delCTGA) and 6 (7.4%) had prostate cancer (two men with BRCA1 c.5266dupC and one man each with BRCA1 c.68_69delAG, BRCA2 c.2808_2811delACAA, BRCA2 c.5946delT, and BRCA2 c.4716_4717delinsAAAGACC). Here, BRCA2 is linked to breast cancer.